POSC41 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Mexico

Abstract

Authors

A Ponce-de-León A Azamar-Alonso F Silva-Sanchez R Chirino-Sprung V Dominguez-Esquivel S Rajme-López

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×